# clm_854E200D3C92

subject: AbbVie (/record/abbvie.md)  
predicate: quarterly_operating_income  
value: 2,798,000,000 United States dollar  
valid_from: 2024-03-31  
valid_to: 2024-06-30  
published: 2024-05-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_9B48C67E536A  
last_updated: 2026-11-08  
cite: AsOf. "AbbVie quarterly operating income: 2,798,000,000 United States dollar", as of 2024-03-31 (until 2024-06-30). Claim clm_854E200D3C92, https://asof.is/claim/clm_854E200D3C92, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000020/0001551152-24-000020-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2024, filed 2024-05-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/1551152/000155115224000020/0001551152-24-000020-index.htm (primary, SEC EDGAR 10-Q Q1 FY2024, published 2024-05-03)

## Supersedes

- [AbbVie](/record/abbvie.md) | quarterly_operating_income | 2,281,000,000 United States dollar | valid 2023-09-30 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_854E200D3C92](/claim/clm_854E200D3C92.md) | [clm_A6F43E732D82](/claim/clm_A6F43E732D82.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.